title: 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
abstract: Since the begining of the year 2005, the use of steroid precursors (prohormones) is illegal in the United States; nevertheless, there is still an enormous abuse of such substances. One of the most frequently misused steroids, often declared to be a prohormone, is 1-testosterone (17beta-hydroxy-5alpha-androst-1-en-3-one, 1-Testo). In this study, we have characterised molecular mechanisms of its action, determined its tissue specific androgenic and anabolic potency and investigated potential adverse effects. 1-Testo binds highly selective to the androgen receptor (AR) and has a high potency to stimulate AR dependent transactivation. In vivo an equimolar dose of 1-Testo has the same potency to stimulate the growth of the prostate, the seminal vesicles and the androgen sensitive levator ani muscle as the reference compound testosterone propionate (TP). Administration of 1-Testo, in contrast to TP, results in a significant increase of liver weight. Our results demonstrate that 1-Testo, even without being metabolised, is a very potent androgen. It binds selectively to the AR and transactivates AR dependent reporter genes. In vivo it has a high androgenic and anabolic potency and increases liver weight. In summary 1-Testo can be characterised as a typical anabolic steroid. It has to be assumed that consumption of this substance is associated with adverse side effects typical for this class of compounds. Therefore, a strict control of its ban is essential.
authors.affiliation: Center for Preventive Doping Research, Institute of Cardiovascular Research and Sports Medicine, Department of Molecular and Cellular Sports Medicine, German Sport University Cologne, 50927 Cologne, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Friedel
authors.forename: H
authors.initials: H
authors.lastname: Geyer
authors.forename: M
authors.initials: M
authors.lastname: Kamber
authors.forename: U
authors.initials: U
authors.lastname: Laudenbach-Leschowsky
authors.forename: W
authors.initials: W
authors.lastname: Schänzer
authors.forename: M
authors.initials: M
authors.lastname: Thevis
authors.forename: G
authors.initials: G
authors.lastname: Vollmer
authors.forename: O
authors.initials: O
authors.lastname: Zierau
authors.forename: P
authors.initials: P
authors.lastname: Diel
mesh_terms: D045930:Anabolic Agents / Q000633:toxicity*; D000818:Animals; D001681:Biological Assay; D015870:Gene Expression; D017930:Genes, Reporter; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008297:Male; D018482:Muscle, Skeletal / Q000187:drug effects / Q000254:growth & development; D009919:Orchiectomy; D009929:Organ Size / Q000187:drug effects; D011467:Prostate / Q000187:drug effects* / Q000254:growth & development; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011944:Receptors, Androgen / Q000235:genetics / Q000378:metabolism*; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000235:genetics; D012669:Seminal Vesicles / Q000187:drug effects* / Q000254:growth & development; D015813:Substance Abuse Detection / Q000379:methods; D013739:Testosterone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000633:toxicity
chemical_list: D045930:Anabolic Agents; D012333:RNA, Messenger; D011944:Receptors, Androgen; D013739:Testosterone; C013915:boldenone